ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetes

ACE genotype, phenotype and all-cause mortality in different cohorts of patients with type 1 diabetes

Aims: Carrying the D-allele of the angiotensin-converting enzyme (ACE) I/D polymorphism and high ACE activity are prognostic factors in diabetic nephropathy, which predicts mortality in type 1 diabetes. We studied the association between the ACE D-allele and ACE phenotype and long-term all-cause mor...

Full description

Bibliographic Details
Main Authors:	Louise H Færch, Anne-Sophie Sejling, Maria Lajer, Lise Tarnow, Birger Thorsteinsson, Ulrik Pedersen-Bjergaard
Format:	Article
Language:	English
Published:	SAGE Publications 2015-06-01
Series:	Journal of the Renin-Angiotensin-Aldosterone System
Online Access:	https://doi.org/10.1177/1470320313494431

Similar Items

Effects of angiotensin II receptor blockade on cerebral, cardiovascular, counter-regulatory, and symptomatic responses during hypoglycaemia in patients with type 1 diabetes
by: Louise H Færch, et al.
Published: (2015-12-01)

Influence of erythropoietin on cognitive performance during experimental hypoglycemia in patients with type 1 diabetes mellitus: a randomized cross-over trial.
by: Peter Lommer Kristensen, et al.
Published: (2013-01-01)

A prospective randomised cross-over study of the effect of insulin analogues and human insulin on the frequency of severe hypoglycaemia in patients with type 1 diabetes and recurrent hypoglycaemia (the HypoAna trial): study rationale and design
by: Kristensen Peter, et al.
Published: (2012-06-01)

Impact of the TCF7L2 genotype on risk of hypoglycaemia and glucagon secretion during hypoglycaemia
by: Peter L Kristensen, et al.
Published: (2016-11-01)

Differences in cortical and pituitary activity in response to hypoglycaemia and cognitive testing in healthy men with different basal activity of the renin-angiotensin system
by: Lise G Bie-Olsen, et al.
Published: (2010-09-01)

The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia
by: Sofie Broeng-Mikkelgaard, et al.
Published: (2023-11-01)

Gustatory sweating in people with type 1 and type 2 diabetes mellitus: Prevalence and risk factors
by: Carina Kirstine Klarskov, et al.
Published: (2021-10-01)

Decreased branched-chain amino acids and elevated fatty acids during antecedent hypoglycemia in type 1 diabetes
by: Ulrik Pedersen-Bjergaard, et al.
Published: (2023-05-01)

Phenotypic but not genetically predicted heart rate variability associated with all-cause mortality
by: Balewgizie S. Tegegne, et al.
Published: (2023-10-01)

Impact of diabesity phenotype on cardiovascular diseases, major cardiovascular events and all-cause mortality
by: Kamran Mehrabani-Zeinabad, et al.
Published: (2023-07-01)

ACE phenotyping in human heart.
by: Victoria E Tikhomirova, et al.
Published: (2017-01-01)

Plasma proteome analysis of patients with type 1 diabetes with diabetic nephropathy
by: Rossing Peter, et al.
Published: (2010-02-01)

The effect of insulin degludec on risk of symptomatic nocturnal hypoglycaemia in adults with type 1 diabetes and high risk of nocturnal severe hypoglycaemia (the HypoDeg trial): study rationale and design
by: Rikke Mette Agesen, et al.
Published: (2019-07-01)

Metabolically Abnormal Non-Obese Phenotype Is Significantly Associated with All-Cause Mortality in Hemodialysis Patients
by: Jin Hyeog Lee, et al.
Published: (2024-02-01)

Inhaled Corticosteroid Therapy in Bronchiectasis is Associated with All-Cause Mortality: A Prospective Cohort Study
by: Håkansson KEJ, et al.
Published: (2021-07-01)

Tissue ACE phenotyping in lung cancer.
by: Sergei M Danilov, et al.
Published: (2019-01-01)

Use of Clopidogrel and Proton Pump Inhibitors Alone or in Combinations in Persons with Diabetes in Denmark; Potential for CYP2C19 Genotype-Guided Drug Therapy
by: Niels Westergaard, et al.
Published: (2021-02-01)

Blood ACE Phenotyping for Personalized Medicine: Revelation of Patients with Conformationally Altered ACE
by: Sergei M. Danilov, et al.
Published: (2023-02-01)

Alcohol and Mortality from All Causes
by: SERGE RENAUD, et al.
Published: (2004-01-01)

The Gamma Gap and All-Cause Mortality.
by: Stephen P Juraschek, et al.
Published: (2015-01-01)

Genotype variation of ACE and ACE2 genes affects the severity of COVID-19 patients
by: Ingrid Faustine, et al.
Published: (2023-09-01)

Faecal haemoglobin concentrations are associated with all-cause mortality and cause of death in colorectal cancer screening
by: Lasse Kaalby, et al.
Published: (2023-01-01)

Genotype-specific reference intervals for serum ACE
by: Celine Gerin, et al.
Published: (2009-10-01)

Systematic review of the utility of the frailty index and frailty phenotype to predict all-cause mortality in older people
by: Kim, DJ, et al.
Published: (2022)

Systematic review of the utility of the frailty index and frailty phenotype to predict all-cause mortality in older people
by: Dani J. Kim, et al.
Published: (2022-09-01)

Phenotype of higher post-load insulin response as a predictor of all-cause mortality and cardiovascular mortality in the Chinese non-diabetic population
by: Xiaoxia Shen, et al.
Published: (2022-01-01)

Angiotensin-converting enzyme activity and cognitive impairment during hypoglycaemia in healthy humans
by: Ulrik Pedersen-Bjergaard, et al.
Published: (2008-03-01)

Predictive potential of ACE phenotyping in extrapulmonary sarcoidosis
by: Sergei M. Danilov, et al.
Published: (2022-08-01)

All-cause and cause-specific mortality in patients with depression in Scotland
by: R. Alotaibi, et al.
Published: (2023-03-01)

All‐cause mortality and Japan's early countermeasures
by: Søren Roest Korsgaard
Published: (2024-02-01)

Urinary ACE Phenotyping as a Research and Diagnostic Tool: Identification of Sex-Dependent ACE Immunoreactivity
by: Alexander J. Kozuch, et al.
Published: (2023-03-01)

Occupational heavy lifting and risk of ischemic heart disease and all-cause mortality
by: Petersen Christina B, et al.
Published: (2012-12-01)

Variations in all-cause mortality, premature mortality and cause-specific mortality among persons with diabetes in Ontario, Canada
by: Laura C Rosella, et al.
Published: (2023-05-01)

Beta-Blockers in High-Risk Outpatients with Chronic Obstructive Pulmonary Disease are Associated with All-Cause Mortality – The STATUETTE Cohort Study
by: Damkjær M, et al.
Published: (2021-08-01)

Motoric Cognitive Risk Syndrome, Subtypes and 8-Year All-Cause Mortality in Aging Phenotypes: The Salus in Apulia Study
by: Ilaria Bortone, et al.
Published: (2022-06-01)

Associations of polycyclic aromatic hydrocarbons mixtures with cardiovascular diseases mortality and all-cause mortality and the mediation role of phenotypic ageing: A time-to-event analysis
by: Siyu Duan, et al.
Published: (2024-04-01)

Micronutrient intake in relation to all-cause mortality in a prospective Danish cohort
by: Nina Roswall, et al.
Published: (2012-04-01)

Association of childhood obesity with risk of early all-cause and cause-specific mortality: A Swedish prospective cohort study.
by: Louise Lindberg, et al.
Published: (2020-03-01)

Macronutrient Quality and All-Cause Mortality in the SUN Cohort
by: Susana Santiago, et al.
Published: (2021-03-01)

Reasons for Hospitalization and All-Cause Mortality for Adults with Sarcoidosis
by: Michael Manansala, et al.
Published: (2023-06-01)